Careful on the no-brainer assumption tricky. History has reason to cast doubt on information supplied by this company (Stem cell growth medium-retracted paper). The key is Prof Keith Harding. For me he gives it credibility, and I hope he hasn't signed onto something which is less than straight truth and fact. That fiasco with the growth factor/retracted paper/association with TIS will be having some bearing on the proceedings here without doubt. Its about credibility in what you say. "Trust me this time!"
TIS Price at posting:
21.0¢ Sentiment: Hold Disclosure: Held
